Clinical implications of growth factors in flexor tendon wound healing

被引:113
作者
Hsu, C
Chang, J
机构
[1] Stanford Univ, Med Ctr, Div Plast Surg, Palo Alto, CA 94304 USA
[2] Dept Vet Affairs, Palo Alto Hlth Care Syst, Div Plast Surg, Palo Alto, CA USA
来源
JOURNAL OF HAND SURGERY-AMERICAN VOLUME | 2004年 / 29A卷 / 04期
关键词
growth factors; flexor tendon; wound healing;
D O I
10.1016/j.jhsa.2004.04.020
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Recent research has focused on the role of growth factors in flexor tendon wound healing. These basic science reports have described the identification and quantification of various growth factors in in vitro and in vivo models. Although these reports have begun to piece together the cascade of events involved in flexor tendon wound healing, the clinical relevance for the practicing hand surgeon is unclear. Growth factors are cell-secreted proteins that regulate cellular functions. These growth factors are involved in cell differentiation and growth, including the normal processes of development and tissue repair. Several growth factors recently have been identified as playing roles in tendon healing including vascular endothelial growth factor (VEGF), insulin-like growth factor (IGF), platelet-derived growth factor (PDGF), basic fibroblast growth factor (bFGF), and transforming growth factor beta (TGF-beta). In addition, the transcription factor NF-kappaB has been implicated in the signaling pathways of these growth factors. The purpose of this article is to describe what is known about the molecular basis of flexor tendon wound healing, to review the most commonly studied growth factors, and to summarize likely clinical applications of these growth factors to flexor tendon repair. Copyright (C) 2004 by the American Society for Surgery of the Hand.
引用
收藏
页码:551 / 563
页数:13
相关论文
共 152 条
[31]   VASCULAR ENDOTHELIAL GROWTH-FACTOR RECEPTOR LOCALIZATION AND ACTIVATION IN HUMAN TROPHOBLAST AND CHORIOCARCINOMA CELLS [J].
CHARNOCKJONES, DS ;
SHARKEY, AM ;
BOOCOCK, CA ;
AHMED, A ;
PLEVIN, R ;
FERRARA, N ;
SMITH, SK .
BIOLOGY OF REPRODUCTION, 1994, 51 (03) :524-530
[32]   THE INSULIN-LIKE GROWTH-FACTORS [J].
COHICK, WS ;
CLEMMONS, DR .
ANNUAL REVIEW OF PHYSIOLOGY, 1993, 55 :131-153
[33]   Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing [J].
Corral, CJ ;
Siddiqui, A ;
Wu, LC ;
Farrell, CL ;
Lyons, D ;
Mustoe, TA .
ARCHIVES OF SURGERY, 1999, 134 (02) :200-205
[34]   Insulin-like growth factor-I improves cellular and molecular aspects of healing in a collagenase-induced model of flexor tendinitis [J].
Dahlgren, LA ;
van der Meulen, MCH ;
Bertram, JEA ;
Starrak, GS ;
Nixon, AJ .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2002, 20 (05) :910-919
[35]  
DEUEL TF, 1991, ANNU REV MED, V42, P567, DOI 10.1146/annurev.med.42.1.567
[36]   THE FMS-LIKE TYROSINE KINASE, A RECEPTOR FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR [J].
DEVRIES, C ;
ESCOBEDO, JA ;
UENO, H ;
HOUCK, K ;
FERRARA, N ;
WILLIAMS, LT .
SCIENCE, 1992, 255 (5047) :989-991
[37]  
DIDONATO JA, 1995, MOL CELL BIOL, V15, P1302
[38]   GROWTH-FACTORS AND CANINE FLEXOR TENDON HEALING - INITIAL STUDIES IN UNINJURED AND REPAIR MODELS [J].
DUFFY, FJ ;
SEILER, JG ;
GELBERMAN, RH ;
HERGRUETER, CA .
JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 1995, 20A (04) :645-649
[39]   VPF/VEGF and the angiogenic response [J].
Dvorak, HF .
SEMINARS IN PERINATOLOGY, 2000, 24 (01) :75-78
[40]   Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open-label clinical evaluation of efficacy [J].
Embil, JM ;
Papp, K ;
Sibbald, G ;
Tousignant, J ;
Smiell, JM ;
Wong, B ;
Lau, CY .
WOUND REPAIR AND REGENERATION, 2000, 8 (03) :162-168